Section Arrow
Quote
ENOV.NYSE
- Enovis Corp
Quotes are at least 15-min delayed:2026/01/22 17:00 EST
After Hours
Last
 23.55
0 (0.00%)
Bid
23.01
Ask
27
High 24.01 
Low 23.55 
Volume 32.88K 
Regular Hours (Closed)
Last
 23.55
-0.13 (-0.55%)
Day High 
24.4595 
Prev. Close
23.68 
1-M High
29.8899 
Volume 
1.42M 
Bid
23.01
Ask
27
Day Low
23.47 
Open
24.08 
1-M Low
22.98 
Market Cap 
1.35B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 25.71 
20-SMA 26.38 
50-SMA 27.65 
52-W High 49.38 
52-W Low 22.98 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-24.34/6.61
Enterprise Value
2.72B
Balance Sheet
Book Value Per Share
35.33
Cash Flow
Cash Flow Yield
0.16
Income Statement
Total Revenue
2.11B
Operating Revenue Per Share
29.04
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories108.61-12.12-10.04%15.3PE
After Hours 109.05 +0.44 +0.41%
BSXBoston Scientific Corp91.29-0.42-0.46%49.04PE
After Hours 90.9 -0.39 -0.43%
DXCMDexCom73.92+1.81+2.51%39.94PE
After Hours 73.92 0 0.00%
PACBPacific Biosciences of California2.67+0.25+10.33%-- 
After Hours 2.66 -0.01 -0.37%
MDTMedtronic plc101.34+1.05+1.05%27.2PE
After Hours 101.34 0 0.00%
Industry overview quotes are at least 15 minutes delayed
Business Description
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.